Breaking News, Collaborations & Alliances

Tonix Pharmaceuticals Selects 2 CMOs to Support Tonmya in the U.S.

Almac Pharma Services will support the commercial launch and ongoing supply of the new non-opioid analgesic to patients with fibromyalgia.

Author Image

By: Charlie Sternberg

Associate Editor

Tonix Pharmaceuticals Inc. Holding Corp., a biopharmaceutical company that has both marketed products and a pipeline of development candidates, has chosen two contract manufacturing organizations (CMOs) to be dual supply sources for the potential launch and commercialization of Tonmya in the United States. One of the CMOs is Almac Pharma Services, which is a member of the privately owned Almac Group.   “Dual sourcing is a critical element for the successful commercial launch and supply chain m...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters